(VIANEWS) - Medpace Holdings (MEDP), Bankwell Financial Group (BWFG), Henry Schein (HSIC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Medpace Holdings (MEDP)
24.1% sales growth and 27.3% return on equity
Medpace Holdings, Inc. offers clinical-based medical device and drug development services throughout North America, Europe, Asia, and the Middle East.
Medpace Holdings's sales growth this year is expected to be 23.5% and 13% for next year.
Year-on-year quarterly revenue growth grew by 27.3%, now sitting on 1.21B for the twelve trailing months.
Volume
Today's last reported volume for Medpace Holdings is 153137 which is 54.29% below its average volume of 335033.
Medpace Holdings's sales growth for the next quarter is 24.1%. The company's growth estimates for the present quarter and the next is 25.5% and 10.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.3%.
Volatility
Medpace Holdings's last day, last week, and last month's current intraday variation average was 0.05%, 0.87%, and 2.12%, respectively.
Medpace Holdings's highest amplitude of average volatility was 3.25% (day), 3.29% (last week), and 3.73% (last month), respectively.
Medpace Holdings's Stock Yearly Top and Bottom Value
Medpace Holdings's stock is valued at $149.60 at 06:22 EST, way under its 52-week high of $231.00 and way above its 52-week low of $126.94.
Medpace Holdings's Moving Average
Medpace Holdings's value is above its 50-day moving average of $140.54 and way below its 200-day moving average of $174.14.2. Bankwell Financial Group (BWFG)
15.5% sales growth and 14.62% return on equity
Bankwell Financial Group, Inc. is the bank holding company of Bankwell Bank. It provides a variety of banking services and products to Connecticut's commercial and residential customers.
Bankwell Financial Group's sales growth this year is expected to be 15% and 0.6% for next year.
Year-on-year quarterly revenue growth grew by 19.7%, now sitting on 76.03M for the twelve trailing months.
Volume
Today's last reported volume for Bankwell Financial Group is 72259 which is 76.84% above its average volume of 40861.
Bankwell Financial Group's sales growth for the next quarter is 15.5%. The company's growth estimates for the ongoing quarter and the next is 29.1% and 12.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.62%.
Volatility
Bankwell Financial Group's last day, last week, and last month's current intraday variation average was 2.82%, 1.97%, and 1.45%, respectively.
Bankwell Financial Group's highest amplitude of average volatility was 5.14% (day), 3.08% (last week), and 2.73% (last month), respectively.
Bankwell Financial Group's Stock Yearly Top and Bottom Value
Bankwell Financial Group's stock is valued at $30.45 at 06:22 EST, way below its 52-week high of $36.87 and way higher than its 52-week low of $26.78.
Bankwell Financial Group's Moving Average
Bankwell Financial Group's worth is way under its 50-day moving average of $33.92 and under its 200-day moving average of $32.56.3. Henry Schein (HSIC)
10.1% sales growth and 14.46% return on equity
Henry Schein, Inc. offers health products and services for dentists, laboratories, doctor practices, government, institution health care clinics, as well as other alternative care clinics around the world.
Henry Schein's sales growth this year is expected to be 5.4% and 3.7% for next year.
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 12.66B for the twelve trailing months.
Volume
Today's last reported volume for Henry Schein is 913465 which is 8.16% above its average volume of 844474.
Henry Schein's sales growth is a negative 0% for the ongoing quarter and 10.1% for the next. The company's growth estimates for the present quarter and the next is 4.5% and 8.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.46%.
Volatility
Henry Schein's last day, last week, and last month's current intraday variation average was 2.02%, 1.10%, and 1.37%, respectively.
Henry Schein's highest amplitude of average volatility was 3.69% (day), 2.39% (last week), and 2.52% (last month), respectively.
Henry Schein's Stock Yearly Top and Bottom Value
Henry Schein's stock is valued at $77.29 at 06:22 EST, way under its 52-week high of $92.68 and way above its 52-week low of $70.25.
Henry Schein's Moving Average
Henry Schein's worth is under its 50-day moving average of $83.49 and below its 200-day moving average of $80.35.4. Barnes Group (B)
8.6% sales growth and 7.23% return on equity
Barnes Group Inc. offers engineered products and industrial technologies as well as solutions both in the United States of America and abroad.
Barnes Group's sales growth this year is expected to be 6.8% and 8.1% for next year.
Year-on-year quarterly revenue growth grew by 3.6%, now sitting on 1.27B for the twelve trailing months.
Volume
Today's last reported volume for Barnes Group is 176946 which is 33.45% below its average volume of 265896.
Barnes Group's sales growth for the next quarter is 8.6%. The company's growth estimates for the current quarter and the next is 8.9% and 12.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.23%.
Volatility
Barnes Group's last day, last week, and last month's current intraday variation average was 1.32%, 1.27%, and 1.75%, respectively.
Barnes Group's highest amplitude of average volatility was 3.08% (day), 3.16% (last week), and 2.78% (last month), respectively.
Barnes Group's Stock Yearly Top and Bottom Value
Barnes Group's stock is valued at $31.55 at 06:22 EST, way under its 52-week high of $52.07 and higher than its 52-week low of $30.22.